Reflector

Group’s ideas to change EU pricing rules draw captive audience.

The risky business of outmaneuvering Europe’s drug pricing authorities.

Fresh round of discussions around health technology assessment.

Efforts for a standardized approach coming to a head in Europe.

European Commission looks to relieve issues without legislation.

Looks to address disconnect between registration and reimbursement.